Rostaporfin: PhotoPoint SnET2, purlytin, Sn(IV) etiopurpurin, SnET2, tin ethyl etiopurpurin

Drugs in R and D

Volumn 5, Issue 1, 2004, Pages 58-61

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ETIOPURPURIN; PHOTOSENSITIZING AGENT; PURLYTIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BREAST CANCER; CLINICAL TRIAL; DISEASE ASSOCIATION; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG MARKETING; DRUG MECHANISM; HUMAN; KAPOSI SARCOMA; NONHUMAN; PHOTOSENSITIVITY DISORDER; PRIORITY JOURNAL; RAT; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; SKIN CANCER; SKIN DISEASE; SKIN METASTASIS; SKIN SENSITIVITY; VISUAL ACUITY;

ANIMALS; DRUGS, INVESTIGATIONAL; HUMANS; NEOPLASMS; PORPHYRINS; RADIATION-SENSITIZING AGENTS;

EID: 1042269528     PISSN: 11745886     EISSN: None     Source Type: Journal    
DOI: 10.2165/00126839-200405010-00013     Document Type: Review

References (7)

1. Frazier DL, Barnhill MA, Vodinh T. Comparative pharmacokinetics of the photosensitizer tin-etiopurpurin in dogs and rats. Journal of Veterinary Pharmacology and Therapeutics 15: 275-281, Sep 1992
2. Polo L, Reddi E, Garbo GM. The distribution of the tumour photosensitizers Zn(II)-phthalocyanine and Sn(IV)-etiopurpurin among rabbit plasma proteins, Cancer Letters 66: 217-223, 21 Oct 1992
3. Pharmaceutical approvals. Pharmaceutical Approvals Monthly: 43, Jan 1996
4. Miravant Purlytin PDT for macular degeneration entering phase II/III, FDC Reports - Pink Sheet - Prescription Pharmaceuticals and Biotechnology 60: 9, 30 Mar 1998
5. Miravant announces positive interim results in cutaneous metastatic breast cancer. BW Health Wire [online]: [2 pages], 2 Dec 1997. Available from URL: http://www.newspage.com
6. Cancer Biotechnology Weekly. Kaposi's sarcoma (treatment); photodynamic-therapy KS data presented. Cancer Biotechnology Weekly [online]: [1 page], 22 Jul 1996. Available from URL: http://www.newspage.com
7. Miravant Medical Technologies. Miravant Updates SnET2 Phase III Clinical Results for Macular Degeneration. Media Release: 27 Aug 2002. Available from URL: http://www.miravant.com